COVID-19 drugs and drug repositioning
dc.contributor.author | Turanalp, İrem Nida | |
dc.date.accessioned | 2024-07-12T21:58:28Z | |
dc.date.available | 2024-07-12T21:58:28Z | |
dc.date.issued | 2021 | en_US |
dc.department | Maltepe Üniversitesi, Rektörlük | en_US |
dc.description.abstract | Introduction: The COVID-19 pandemic is caused by SARS-CoV-2. Drug repositioning is a propitious field in the development and discovery of therapeutic agents that distinguishes new therapeutic options for existing drugs. There are repositioned drugs in COVID-19 treatment. Aim: We aimed to explore repositioned drugs for COVID-19 pharmacotherapy. We further classify the drugs according to ATC-DDD pharmacological category. Materials and Methods: Drugs are retrieved from the NIH guideline and national guideline. NIH and national guidelines are compared for treatment approaches. Result and Discussion: Remdesivir, hydroxychloroquine, lopinavir-ritonavir, favipiravir, tocilizumab and interferon regimens are found to be repurposed in clinical guidelines. Hydroxychloroquine is in P01BA group, lopinavir-ritonavir is in J05AX group, interferons are in L03AB group, and favipiravir is in J05AX group. A recent study obtained 21 preexisting drugs which are effectual at blocking SARS-CoV-2 viral replication. Two of them are already FDA approved which are astemizole and clofazimine. 13 of them have been clinically tested and have proved the e ectiveness against SARS-CoV-2, 4 of them have shown that they work synergistically with remdesivir. Remdesivir and corticosteroids are currently recommended by NIH to the hospitalized patients with COVID-19 for their treatment. | en_US |
dc.identifier.citation | Turanalp, İ.N. (2021). COVID-19 drugs and drug repositioning. International Faculty of Medical Sciences and Nursing(MEDNS) Student Congress, Maltepe Üniversitesi. s. 54-55. | en_US |
dc.identifier.endpage | 55 | en_US |
dc.identifier.isbn | 978-605-2124-39-0 | |
dc.identifier.startpage | 54 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12415/8810 | |
dc.language.iso | en | en_US |
dc.publisher | Maltepe Üniversitesi | en_US |
dc.relation.ispartof | International Faculty of Medical Sciences and Nursing(MEDNS) Student Congress | en_US |
dc.relation.publicationcategory | Uluslararası Konferans Öğesi - Başka Kurum Yazarı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | KY08058 | |
dc.subject | Drug repositioning | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Pandemic | en_US |
dc.title | COVID-19 drugs and drug repositioning | en_US |
dc.type | Conference Object | |
dspace.entity.type | Publication |